MSLN and neoplasm: On the one hand, clinical observations indicate that elevated MSLN expression is associated with increase in tumor burden and poor overall survival in patients of various cancers10–16, and on the other hand, MSLN’s normal expression is limited to mesothelial cells, which are dispensable without substantial adverse side effects.